Skip to content

Study for confirming anti-obesity effect by ingesting test food (preliminary examination)

Study for confirming anti-obesity effect by ingesting test food (preliminary examination) - Study for confirming anti-obesity effect by ingesting test food (preliminary examination)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037428
Enrollment
40
Registered
2020-07-22
Start date
2019-07-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male

Interventions

Intake test foods for 12 weeks. Intake control foods for 12 weeks.

Sponsors

CPCC CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Males aged 20 to 59 when informed consent. (2) Subjects whose body mass index (BMI) is included between 23.0 kg/m^2 to less than 30.0 kg/m^2. (3) Subjects giving written informed consent.

Exclusion criteria

Exclusion criteria: (1) Subjects who are given continuous treatment by taking medicines. (2) Subjects who having Food for Specified Health Uses (FOSHU), functional food, health food and/or supplements having a possibility of affecting test results. (3) Subjects who have weak digestive organ. Especially subjects who may feel discomfort for example stomach astigmatism after intake of drinks containing tannin like strong green tea, black tea and coffee. (4) Subjects who are severe anemia, or who have been diagnosed with severe anemia by the doctor (5) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). (6) Subjects who excessive alcohol intake. (7) Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. (8) Subjects who have previous medical history of drug and/or food allergy. (9) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. (10) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. (11) Subjects who donated over 400mL blood and/or blood components within the last three month to the current study. (12) Subjects who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. (13) Others who have been determined ineligible by principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
Body weight BMI Body fat percentage Visceral fat area

Secondary

MeasureTime frame
Amount of liver fat Fatty liver Waist circumference Incidence of adverse events and/or side effects

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC CO., LTD. Plan Sales Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026